It is worth noting that Akili Interactive’s study – by doctors working for EndeavorRX’s developer – came to the conclusion that there isn’t enough evidence to suggest that this game should be used as a replacement for established ADHD treatments, but that it can be used in addition to existing treatments.
The game, which is only available on prescription (and which you can join a waiting list for) sees you travelling on a raft down rivers in various fantastical locations, collecting targets and dodging obstacles. Your character can even be equipped with various different costumes from a rotating selection. You can watch a short gameplay trailer to get a sense of it
You can check out the full news release from the FDA here, which explains why the landmark decision was made and describes the game as “the first digital therapeutic intended to improve symptoms associated with ADHD.”
“The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics,” notes Jeffery Shuren, director of the FDA’s Center for Devices and Radiological Health.
Jordan Oloman is a freelance writer for IGN. Follow him on Twitter.